Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FAM169A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
COCH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ROR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CENPV - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EPCAM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NR2F2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM101B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100996809 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
E2F7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC6A15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM19A5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPINT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTAG1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
CTAG2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TEKT4P2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLXND1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HTR2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
THEMIS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on